Prohance (gadoteridol) injection label

First Page		Document Content
Date: 2010-12-21 14:29:00 Nephrogenic systemic fibrosis Nephrology Organic chemistry Gadoteridol Aspirin Ketorolac MRI contrast agent Gadodiamide Chemistry Non-steroidal anti-inflammatory drugs Medicine		Prohance (gadoteridol) injection label Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 108,77 KB Share Document on Facebook

	Prohance (gadoteridol) injection label DocID: G7wG - View Document
	AVAILABLE FOR PUBLIC DISCLOSURE WITHOUT REDACTION Page: 2 of DocID: D2qm - View Document
	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived DocID: Cko2 - View Document
	[removed]Gadobutrol Statistical PREA DocID: BTRF - View Document
	Microsoft Word - DDR letter - final with signatures[removed]mcm.doc DocID: Bbtf - View Document